ACCENDRA HEALTH INC/VA/
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.8B | $2.7B | $2.6B | $10.0B | $9.8B |
| Gross profit | — | $2.2B | $2.1B | $1.8B | $1.5B |
| Operating income | $27.5M | -$217.7M | $133.2M | $142.9M | $368.5M |
| Cost of revenue | $1.5B | $1.4B | $1.3B | $8.1B | $8.3B |
| Cash from operations | -$101.8M | $161.5M | $740.7M | $325.0M | $124.2M |
| Capital expenditure | $191.0M | $170.3M | $172.4M | $158.1M | $41.0M |
| Free cash flow | -$292.7M | -$8.8M | $568.3M | $166.9M | $83.2M |
| Share repurchases | $10.2M | — | — | — | — |
| Impairments | $0 | $307.1M | $0 | $0 | $0 |
| Total assets | $2.5B | $4.7B | $5.1B | $5.4B | $3.5B |
| Total liabilities | $2.9B | $4.1B | $4.2B | $4.4B | $2.6B |
Shares outstanding 76.6M · Free float 54.6%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.